Phase
Condition
Heart Disease
Coronary Artery Disease
Cardiac Ischemia
Treatment
N/AClinical Study ID
Ages 18-120 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 years
Patients diagnosed as acute coronary syndromes including acute ST-segment elevationmyocardial infarction (STEMI) and non-ST-segment elevated acute coronary syndrome (NSTE-ACS)
Patients or whose legal representatives signed written informed consent form
Exclusion
Exclusion Criteria: Patients should been excluded if they meet any of the following exclusion criteria:
- Patients with contraindications to the application of beta blockers, including: 1)cardiogenic shock or heart failure (Killip grade > II level);2) sick sinus syndrome;
- II degree atrioventricular block;4) unstable decompensation of cardiac failure (pulmonary edema, hypotension or low perfusion); 5) symptomatic hypotension orbradycardia (heart rate<50 beats/min, blood pressure<90/60mmHg); 6) contraindicationsto beta blockers or allergy to any ingredient of beta blocker; 7) active asthma shouldbe treated by inhalation preparation treatment
Pregnant or lactating women
Patients without signed written informed consent
Patients who was considered by the researcher inappropriate to participate in thisstudy (for example, patients with a higher risk of cardiogenic shock, etc.)
Study Design
Connect with a study center
Fuwai Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing 100037
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.